Harry Sloan
Harry Sloan's purchase track record
How the stock did after each of Harry Sloan's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/17/2026 | DKNG | $2.19M | +13.1% | +6.4% | +12.4% |
| 11/11/2025 | DKNG | $758K | -11.1% | -19.3% | +8.1% |
| 8/19/2025 | STRZ | $202K | -11.4% | -31.0% | +6.7% |
| 5/14/2024 | DNA | $272K | -67.4% | -75.7% | +14.1% |
| 5/18/2023 | DNA | $448K | +22.0% | +10.6% | +7.4% |
| 11/22/2022 | STRZ | $640K | pending | pending | — |
| 9/29/2022 | STRZ | $353K | pending | pending | — |
| 4/22/2022 | STRZ | $636K | pending | pending | — |
| 3/14/2022 | FIRY | $227K | -34.4% | -35.4% | -1.5% |
| 2/28/2022 | FIRY | $294K | -38.9% | -56.0% | -7.8% |
| 2/15/2022 | STRZ | $649K | pending | pending | — |
| 11/9/2021 | FIRY | $998K | -67.1% | -86.9% | -14.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
DraftKings hits 52-week low amid gambling scrutiny. DraftKings shares recently fell to a 52-week low, a move that coincides with a report that a ProPublica journalist lost money on the platform while receiving VIP rewards. This incident adds to ongoing concerns about the company's user experience and regulatory risks. With the stock down significantly this year, investors are weighing these operational issues against the broader competitive landscape, including new advertising spending by rivals.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Starz Entertainment Included in Communication Services Stock List. Starz Entertainment was featured in a Benzinga article listing nine Communication Services stocks moving during Wednesday's intraday session. The stock is currently trading near its 52-week low, with technical signals indicating a breakdown and high volatility. This inclusion highlights current market attention on the company's price action within its sector.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Analysts Reassess AI Demand, Lift Ginkgo Bioworks Fair Value. Analysts have updated their view on Ginkgo Bioworks, raising its fair value after a renewed focus on AI applications in biotechnology. TD Cowen kept a hold rating but lifted its target price to $11, reflecting optimism about the company’s growth prospects. The stock has been trading below its 52‑week low and fell more than the broader market, suggesting investors are still cautious.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Firy Inc. Class A Shares Included in Recent Intraday Movers. Firy Inc. Class A shares were listed among communication services stocks that experienced intraday price movement on Tuesday and Wednesday, according to Benzinga reports. The activity reflects short‑term volatility in the sector and may influence short‑term trading decisions. With an RSI of 62.9 and a support level near $9.67, the stock remains in a moderate strength zone, while analysts target an average price of $9.17.
Transaction History
| LION | ▲ Buy | Grant | 13,405 | $0 | 9/15/2026 | View on chart |
| LION | ▲ Buy | Grant | 5,362 | $60K | 9/15/2026 | View on chart |
| DKNG | ▲ Buy | Option Exercise | 5,562 | — | 5/12/2026 | View on chart |
| LION | ▲ Buy | Grant | 6,828 | $65K | 4/1/2026 | View on chart |
| DKNG | ▲ Buy | Open Market | 100,000 | $2.2M | 2/17/2026 | View on chart |
| DKNG | ▲ Buy | Option Exercise | 507 | — | 2/10/2026 | View on chart |
| STRZ | ▲ Buy | Grant | 4,753 | $50K | 1/27/2026 | View on chart |
| LION | ▼ Sell | Tax Withholding | 0 | $0 | 11/29/2025 | View on chart |
| LION | ▲ Buy | Grant | 20,107 | $0 | 11/28/2025 | View on chart |
| LION | ▲ Buy | Grant | 8,723 | $65K | 11/28/2025 | View on chart |
| DKNG | ▲ Buy | Open Market | 25,000 | $758K | 11/11/2025 | View on chart |
| DKNG | ▲ Buy | Option Exercise | 491 | — | 11/6/2025 | View on chart |
| STRZ | ▲ Buy | Open Market | 8,100 | $105K | 8/21/2025 | View on chart |
| STRZ | ▲ Buy | Open Market | 1,082 | $14K | 8/20/2025 | View on chart |
| STRZ | ▲ Buy | Open Market | 6,614 | $83K | 8/19/2025 | View on chart |
| DKNG | ▲ Buy | Option Exercise | 305 | — | 8/5/2025 | View on chart |
| STRZ | ▲ Buy | Grant | 1,112 | $0 | 7/30/2025 | View on chart |
| DNA | ▲ Buy | Option Exercise | 10,822 | — | 6/11/2025 | View on chart |
| DKNG | ▼ Sell | Gift | 100 | $0 | 6/3/2025 | View on chart |
| DKNG | ▲ Buy | Option Exercise | 6,969 | — | 5/19/2025 | View on chart |
| STRZ | ▼ Sell | Other | 25,351 | $0 | 5/6/2025 | View on chart |
| DKNG | ▲ Buy | Option Exercise | 409 | — | 5/6/2025 | View on chart |
| LION | ▼ Sell | Other | 380,255 | $0 | 5/6/2025 | View on chart |
| STRZ | ▼ Sell | Other | 72,324 | $0 | 5/6/2025 | View on chart |
| STRZ | ▼ Sell | Other | 277,113 | $0 | 5/6/2025 | View on chart |
| STRZ | ▲ Buy | Grant | 3,238 | $25K | 4/1/2025 | View on chart |
| STRZ | ▲ Buy | Grant | 2,897 | $25K | 4/1/2025 | View on chart |
| DKNG | ▼ Sell | Gift | 100,000 | $0 | 2/19/2025 | View on chart |
| DKNG | ▲ Buy | Option Exercise | 316 | — | 2/11/2025 | View on chart |
| DNA | ▼ Sell | Other | 235,780 | — | 12/11/2024 | View on chart |
| STRZ | ▲ Buy | Grant | 3,034 | $25K | 11/29/2024 | View on chart |
| STRZ | ▲ Buy | Grant | 9,102 | $0 | 11/29/2024 | View on chart |
| STRZ | ▲ Buy | Grant | 3,392 | $25K | 11/29/2024 | View on chart |
| STRZ | ▲ Buy | Grant | 10,176 | $0 | 11/29/2024 | View on chart |
| DNA | ▼ Sell | Other | 4,222 | — | 11/22/2024 | View on chart |
| DKNG | ▼ Sell | Gift | 250,000 | $0 | 11/12/2024 | View on chart |
| DKNG | ▲ Buy | Option Exercise | 352 | — | 11/7/2024 | View on chart |
| DKNG | ▲ Buy | Option Exercise | 383 | — | 7/30/2024 | View on chart |
| DKNG | ▼ Sell | Open Market | 250,000 | $9.5M | 6/14/2024 | View on chart |
| DKNG | ▼ Sell | Gift | 500,000 | $0 | 6/13/2024 | View on chart |
| DKNG | ▼ Sell | Gift | 500,000 | $0 | 6/13/2024 | View on chart |
| DNA | ▲ Buy | Option Exercise | 105,263 | — | 6/12/2024 | View on chart |
| DNA | ▲ Buy | Open Market | 297,619 | $272K | 5/14/2024 | View on chart |
| DKNG | ▲ Buy | Option Exercise | 6,339 | — | 5/13/2024 | View on chart |
| DKNG | ▲ Buy | Option Exercise | 330 | — | 4/30/2024 | View on chart |
| DKNG | ▼ Sell | Gift | 18,000 | $0 | 3/1/2024 | View on chart |
| DKNG | ▼ Sell | Gift | 25,000 | $0 | 3/1/2024 | View on chart |
| DKNG | ▲ Buy | Option Exercise | 929,099 | — | 2/16/2024 | View on chart |
| DKNG | ▼ Sell | Tax Withholding | 254,354 | $10.7M | 2/16/2024 | View on chart |
| DKNG | ▲ Buy | Option Exercise | 322 | — | 2/13/2024 | View on chart |
| STRZ | ▲ Buy | Grant | 2,818 | $25K | 11/28/2023 | View on chart |
| STRZ | ▲ Buy | Grant | 8,455 | $0 | 11/28/2023 | View on chart |
| STRZ | ▲ Buy | Grant | 2,990 | $25K | 11/28/2023 | View on chart |
| STRZ | ▲ Buy | Grant | 8,971 | $0 | 11/28/2023 | View on chart |
| DKNG | ▲ Buy | Option Exercise | 497 | — | 10/31/2023 | View on chart |
| DKNG | ▲ Buy | Option Exercise | 514 | — | 8/1/2023 | View on chart |
| DNA | ▲ Buy | Open Market | 350,000 | $448K | 5/18/2023 | View on chart |
| DKNG | ▲ Buy | Option Exercise | 13,342 | — | 5/2/2023 | View on chart |
| DKNG | ▲ Buy | Option Exercise | 737 | — | 5/2/2023 | View on chart |
| STRZ | ▲ Buy | Grant | 1,680 | $17K | 4/3/2023 | View on chart |
| STRZ | ▲ Buy | Grant | 2,306 | $25K | 4/3/2023 | View on chart |
| STRZ | ▲ Buy | Grant | 2,453 | $25K | 4/3/2023 | View on chart |
| STRZ | ▲ Buy | Grant | 1,786 | $17K | 4/3/2023 | View on chart |
| DKNG | ▲ Buy | Option Exercise | 978 | — | 2/14/2023 | View on chart |
| STRZ | ▲ Buy | Open Market | 100,000 | $640K | 11/22/2022 | View on chart |
| DKNG | ▲ Buy | Option Exercise | 1,020 | — | 11/2/2022 | View on chart |
| STRZ | ▲ Buy | Grant | 2,073 | $15K | 10/1/2022 | View on chart |
| STRZ | ▲ Buy | Grant | 1,954 | $15K | 10/1/2022 | View on chart |
| STRZ | ▲ Buy | Open Market | 50,000 | $353K | 9/29/2022 | View on chart |
| STRZ | ▲ Buy | Grant | 2,434 | $0 | 9/13/2022 | View on chart |
| STRZ | ▲ Buy | Grant | 2,583 | $0 | 9/13/2022 | View on chart |
| DKNG | ▲ Buy | Option Exercise | 1,057 | — | 8/2/2022 | View on chart |
| DNA | ▲ Buy | Grant | 70,921 | $0 | 6/10/2022 | View on chart |
| DKNG | ▲ Buy | Grant | 158,706 | — | 5/5/2022 | View on chart |
| STRZ | ▲ Buy | Open Market | 50,000 | $636K | 4/22/2022 | View on chart |
| STRZ | ▲ Buy | Grant | 488 | $7K | 4/1/2022 | View on chart |
| STRZ | ▲ Buy | Grant | 454 | $7K | 4/1/2022 | View on chart |
| FIRY | ▲ Buy | Open Market | 100,000 | $227K | 3/14/2022 | View on chart |
| FIRY | ▲ Buy | Open Market | 94,880 | $294K | 2/28/2022 | View on chart |
| STRZ | ▲ Buy | Open Market | 28,070 | $362K | 2/16/2022 | View on chart |
| STRZ | ▲ Buy | Open Market | 21,930 | $287K | 2/15/2022 | View on chart |
| FIRY | ▲ Buy | Grant | 10,463 | $85K | 12/16/2021 | View on chart |
| FIRY | ▲ Buy | Grant | 6,080 | $49K | 12/16/2021 | View on chart |
| FIRY | ▲ Buy | Open Market | 80,000 | $998K | 11/9/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Lionsgate faces debt and TV studio concerns
Recent analysis highlights Lionsgate's significant debt load and underperforming TV studio results. These factors contrast with the company's broader entertainment IP portfolio, which includes major franchises like The Hunger Games. The stock currently trades near its 52-week low, reflecting these ongoing financial pressures.
Lionsgate faces debt and TV studio concerns. Recent analysis highlights Lionsgate's significant debt load and underperforming TV studio results. These factors contrast with the company's broader entertainment IP portfolio, which includes major franchises like The Hunger Games. The stock currently trades near its 52-week low, reflecting these ongoing financial pressures.